| Literature DB >> 35327705 |
Francesco Licciardi1, Marco Petraz2, Carlotta Covizzi1, Francesca Santarelli1, Carlotta Cirone1, Roberta Mulatero1, Francesca Robasto1, Marta Dellepiane1, Silvana Martino1, Davide Montin1, Viviana Ravagnani3.
Abstract
Clinical examination (CE) and musculoskeletal ultrasound (MSUS) of ten joints (knee, ankle, wrist, elbow, II-MCP) and their extra-articular (EA) compartments (tendons and bursae) were performed on 35 consecutive patients with active juvenile idiopathic arthritis (JIA) (active group) to test how the extension of MSUS examinations to EA changes the concordance between MSUS and CE. The overall concordance between CE and MSUS, measured with Cohen's Kappa (k), was moderate (k = 0.43); the addition of EA MSUS increased the concordance in all joints, with the exclusion of II-MCP (k = 0.49). In the ankle and wrist, the k increase was relevant (k from 0.13 to 0.27 and 0.11 to 0.41). In the active group patients, we observed 44 subclinical synovitis; the number of subclinical synovitis per patient was correlated with JADAS-27 (p = 0.03) and was higher in a control group composed of 15 patients with persistent disease remission (1.3 vs. 0.4 p = 0.03). Our results show that EA compartments should always be evaluated during MSUS. Furthermore, we demonstrate a moderate concordance between CE and MSUS in JIA; the finding of subclinical synovitis is common in patients with active diseases and is related to disease activity.Entities:
Keywords: JIA; MSUS; juvenile idiopathic arthritis; ultrasound
Year: 2022 PMID: 35327705 PMCID: PMC8947146 DOI: 10.3390/children9030333
Source DB: PubMed Journal: Children (Basel) ISSN: 2227-9067
Demographic, clinical, and laboratory features, and CE−/US+ in the active and remission groups. ESR, erythrocyte sedimentation rate; CRP, C reactive protein; ANA, anti-nuclear antibodies, CE, clinical examination; US, ultrasound. Of note, disease duration is significantly higher in the remission group while the number of CE−/US+ joints per patient is higher in patients with active disease.
| Active Group | Remission Group | ||
|---|---|---|---|
| Total number of patients | 35 | 15 | - |
| Female patients % | 80.0% | 73.3% | |
| Mean age (months) | 102.7 ± 51.5 | 94 ± 39.5 | |
| ILAR category | 21 with oligoarthritis (60%); | 9 with oligoarthritis (60%); | |
| Mean disease duration (months) | 27.7 ± 39.5 | 55.7 ± 37.1 | |
| Disease status | 16 disease onset (45.7%); | 15 disease remission | |
| ESR (n.v. < 20 mm/h) | 20.8 ± 20.5 | 4.3± 4.8 | |
| CRP (n.v. < 5 mg/L) | 7.4 ± 12.7 | 2.6 ± 2.7 | |
| ANA positivity | 17 (48.6%) | 6 (40.0%) | |
| CE+/US+ | 1.0 ±1.2 | 0 | |
| CE−/US+ per patient | 1.3 ± 1.3 | 0.4 ± 0.7 |
Joints with synovitis at clinical examination (CE) and/or at the MSUS (US). Numbers are expressed as % of total joints assessed. US, ultrasound; CE, clinical examination; MCP metacarpophalangeal joint. In bold are expressed significant p-values.
| CE+ | CE− | ||
|---|---|---|---|
| ELBOW | US+ | 7% | 0% |
| US− | 2% | 91% | |
| KNEE | US+ | 31% | 24% |
| US− | 4% | 41% | |
| WRIST | US+ | 1% | 7% |
| US− | 6% | 86% | |
| ANKLE | US+ | 9% | 21% |
| US− | 11% | 59% | |
| II MCP | US+ | 4% | 10% |
| US− | 1% | 85% | |
| TOTAL | US+ | 11% | 13% |
| US− | 5% | 71% | |
Concordance between physical examinations and MSUS, considering the articular compartment alone and the articular + extra-articular compartment. Concordance was evaluated using Cohen’s Kappa coefficient (k). C.I., confidence interval; MCP metacarpophalangeal joint.
| Articular Compartment | Articular + Extra-Articular Compartment | |
|---|---|---|
| ELBOW | k = 0.89 | k = 0.89 |
| KNEE | k = 0.45 | k = 0.48 |
| WRIST | k = 0.11 | k = 0.41 |
| ANKLE | k = 0.13 | k = 0.27 |
| II MCP | k = 0.38 | k = 0.29 |
| TOTAL | k = 0.43 | k = 0.49 |
Figure 1The comparison between the sum of grading (synovial hyperplasia + synovial effusion + PD) in the knee. US, ultrasound; CE, clinical examination.
Figure 2Graphic representation of the linear association between the number of subclinical synovitis (Sub-S: CE−/US+) per patient and JADAS-27 in the active group (p = 0.03, R2 = 0.14). C.I., confidence interval.